Literature DB >> 8524813

A mouse model for beta 0-thalassemia.

B Yang1, S Kirby, J Lewis, P J Detloff, N Maeda, O Smithies.   

Abstract

We have used a "plug and socket" targeting technique to generate a mouse model of beta 0-thalassemia in which both the b1 and b2 adult globin genes have been deleted. Mice homozygous for this deletion (Hbbth-3/Hbbth-3) die perinatally, similar to the most severe form of Cooley anemia in humans. Mice heterozygous for the deletion appear normal, but their hematologic indices show characteristics typical of severe thalassemia, including dramatically decreased hematocrit, hemoglobin, red blood cell counts, mean corpuscular volume, mean corpuscular hemoglobin, and mean corpuscular hemoglobin concentration, as well as dramatically increased reticulocyte counts, serum bilirubin concentrations, and red cell distribution widths. Tissue and organ damage typical of beta-thalassemia, such as bone deformities and splenic enlargement due to increased hematopoiesis, are also seen in the heterozygous animals, as is spontaneous iron overload in the spleen, liver, and kidneys. The mice homozygous for the b1 and b2 deletions should be of great value in developing therapies for the treatment of thalassemias in utero. The heterozygous animals will be useful for studying the pathophysiology of thalassemias and have the potential of generating a model of sickle cell anemia when mated with appropriate transgenic animals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8524813      PMCID: PMC40451          DOI: 10.1073/pnas.92.25.11608

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  GRANULAR GLAND DEVELOPMENT DURING XENOPUS LAEVIS METAMORPHOSIS.

Authors:  J W VANABLE
Journal:  Dev Biol       Date:  1964-12       Impact factor: 3.582

2.  Pathogenetic mechanisms in hepatic cirrhosis of thalassemia major: light and electron microscopic studies.

Authors:  T C Iancu; B H Landing; H B Neustein
Journal:  Pathol Annu       Date:  1977

3.  Tissue iron deposition in untransfused beta-thalassemic mice.

Authors:  L M Garrick; L A Strano-Paul; J E Hoke; L A Kirdani-Ryan; R A Alberico; M M Everett; R M Bannerman; M D Garrick
Journal:  Exp Hematol       Date:  1989-06       Impact factor: 3.084

Review 4.  Hereditary anemias of the mouse: a review for geneticists.

Authors:  E S Russell
Journal:  Adv Genet       Date:  1979       Impact factor: 1.944

5.  DNA sequence organization of the beta-globin complex in the BALB/c mouse.

Authors:  C L Jahn; C A Hutchison; S J Phillips; S Weaver; N L Haigwood; C F Voliva; M H Edgell
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

6.  Compensatory increase in levels of beta minor globin in murine beta-thalassemia is under translational control.

Authors:  M J Curcio; P Kantoff; M P Schafer; W F Anderson; B Safer
Journal:  J Biol Chem       Date:  1986-12-05       Impact factor: 5.157

7.  Hematology of a murine beta-thalassemia: a longitudinal study.

Authors:  R A Popp; D M Popp; F M Johnson; L C Skow; S E Lewis
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

8.  Iron homeostasis in beta-thalassemic mice.

Authors:  D B Van Wyck; M E Tancer; R A Popp
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

9.  A mouse model for beta-thalassemia.

Authors:  L C Skow; B A Burkhart; F M Johnson; R A Popp; D M Popp; S Z Goldberg; W F Anderson; L B Barnett; S E Lewis
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

10.  Seasonal iron overload in Svalbard reindeer liver.

Authors:  B Borch-Iohnsen; K J Nilssen
Journal:  J Nutr       Date:  1987-12       Impact factor: 4.798

View more
  98 in total

1.  UBE2O remodels the proteome during terminal erythroid differentiation.

Authors:  Anthony T Nguyen; Miguel A Prado; Paul J Schmidt; Anoop K Sendamarai; Joshua T Wilson-Grady; Mingwei Min; Dean R Campagna; Geng Tian; Yuan Shi; Verena Dederer; Mona Kawan; Nathalie Kuehnle; Joao A Paulo; Yu Yao; Mitchell J Weiss; Monica J Justice; Steven P Gygi; Mark D Fleming; Daniel Finley
Journal:  Science       Date:  2017-08-04       Impact factor: 47.728

Review 2.  Vasculopathy and pulmonary hypertension in sickle cell disease.

Authors:  Karin P Potoka; Mark T Gladwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-14       Impact factor: 5.464

Review 3.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

Review 4.  Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.

Authors:  Sara Gardenghi; Robert W Grady; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2010-10-15       Impact factor: 3.722

Review 5.  Protein quality control during erythropoiesis and hemoglobin synthesis.

Authors:  Eugene Khandros; Mitchell J Weiss
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

6.  Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.

Authors:  Carla Casu; Mariateresa Pettinato; Alison Liu; Mariam Aghajan; Vania Lo Presti; Maria Rosa Lidonnici; Kevin A Munoz; Emir O'Hara; Violante Olivari; Simona Maria Di Modica; Sheri Booten; Shuling Guo; Garry Neil; Reem Miari; Nir Shapir; Inbal Zafir-Lavie; Hagit Domev; Giuliana Ferrari; Despina Sitara; Antonella Nai; Stefano Rivella
Journal:  Blood       Date:  2020-10-22       Impact factor: 22.113

7.  Insights into hemoglobin assembly through in vivo mutagenesis of α-hemoglobin stabilizing protein.

Authors:  Eugene Khandros; Todd L Mollan; Xiang Yu; Xiaomei Wang; Yu Yao; Janine D'Souza; David A Gell; John S Olson; Mitchell J Weiss
Journal:  J Biol Chem       Date:  2012-01-27       Impact factor: 5.157

Review 8.  Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches.

Authors:  Paul J Schmidt; Mark D Fleming
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

9.  Intestinal HIF2α promotes tissue-iron accumulation in disorders of iron overload with anemia.

Authors:  Erik R Anderson; Matthew Taylor; Xiang Xue; Sadeesh K Ramakrishnan; Angelical Martin; Liwei Xie; Bryce X Bredell; Sara Gardenghi; Stefano Rivella; Yatrik M Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

10.  An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.

Authors:  Paul J Schmidt; Iva Toudjarska; Anoop K Sendamarai; Tim Racie; Stuart Milstein; Brian R Bettencourt; Julia Hettinger; David Bumcrot; Mark D Fleming
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.